Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 523Neoplasms 436Carcinoma, Non-Small-Cell Lung 409Prostatic Neoplasms 325Colorectal Neoplasms 312Lung Neoplasms 259Multiple Myeloma 226Neoplasm Metastasis 194Leukemia, Myeloid, Acute 180Pancreatic Neoplasms 176Ovarian Neoplasms 174Melanoma 146Squamous Cell Carcinoma of Head and Neck 137Carcinoma, Hepatocellular 117Stomach Neoplasms 114Carcinoma, Renal Cell 114Endometrial Neoplasms 110Recurrence 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Head and Neck Neoplasms 109Lymphoma 108Lymphoma, Non-Hodgkin 104Glioblastoma 104Brain Neoplasms 100Uterine Cervical Neoplasms 95Urinary Bladder Neoplasms 93Hematologic Neoplasms 92Triple Negative Breast Neoplasms 90Glioma 87Leukemia, Lymphocytic, Chronic, B-Cell 86

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × 30 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡